UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Kintegral Advisory LLC

Kintegral Advisory LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 27.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,720 shares of the healthcare conglomerate’s stock after selling 3,218 shares during the period. Kintegral Advisory LLC’s holdings in UnitedHealth Group were worth $4,441,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. International Assets Investment Management LLC lifted its stake in shares of UnitedHealth Group by 1.9% during the fourth quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock worth $2,352,000 after buying an additional 85 shares during the period. GUNN & Co INVESTMENT MANAGEMENT INC. raised its holdings in shares of UnitedHealth Group by 1,337.3% during the fourth quarter. GUNN & Co INVESTMENT MANAGEMENT INC. now owns 97,679 shares of the healthcare conglomerate’s stock worth $51,425,000 after purchasing an additional 90,883 shares during the last quarter. Principle Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. Principle Wealth Partners LLC now owns 7,530 shares of the healthcare conglomerate’s stock worth $3,964,000 after purchasing an additional 119 shares during the last quarter. Omnia Family Wealth LLC raised its holdings in shares of UnitedHealth Group by 45.7% during the fourth quarter. Omnia Family Wealth LLC now owns 603 shares of the healthcare conglomerate’s stock worth $317,000 after purchasing an additional 189 shares during the last quarter. Finally, Stonebrook Private Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at $1,488,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, August 21st. Argus lifted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Barclays lifted their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Finally, UBS Group boosted their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. One equities research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Price Performance

UNH traded up $1.13 on Wednesday, reaching $588.48. 1,655,708 shares of the company’s stock were exchanged, compared to its average volume of 4,121,214. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The stock has a market cap of $541.63 billion, a PE ratio of 35.97, a P/E/G ratio of 1.61 and a beta of 0.59. The stock’s fifty day moving average price is $541.92 and its 200-day moving average price is $510.85. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $592.84.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period in the previous year, the business posted $6.14 EPS. UnitedHealth Group’s revenue was up 6.4% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.43%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Insider Activity

In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.